Document is current
Any future updates will be listed below
-
Authors
Girbig, Renée M.
Rix, Anne
Baier, Jasmin
Tix, Leonie
Hartmann, Anna M.
Liu, Wenjia
Paschenda, Pascal
Florea, Alexandru
Sadeghzadeh, Masoud
Becker, Karolin
Palme, Rupert
Mottaghy, Felix M.
Tolba, René
Kiessling, Fabian https://orcid.org/0000-0002-7341-0399
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (321137804)
- License Information
-
More Information
Article History
Received: 16 May 2025
Accepted: 6 October 2025
First Online: 4 November 2025
Declarations
:
: The full ethical proposal was approved by the responsible authority (LANUV NRW–“Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen”, Recklinghausen, Germany, AZ: 84-02.04.2017.A304). All animals in the present study received human care according to the principles of the “Guide for the Care and Use of Laboratory Animals” (8th edition, NIH Publication, 2011, USA).
: FMM is a medical advisor and consultant for Advanced Accelerator Applications (AAA) GmbH/Novartis, Telix Pharmaceuticals, and CURIUM TM, and has recently received institutional grants from NanoMab Technology Ltd., Radiopharm Ltd., Siemens Healthcare, and GE Precision Healthcare LLC. FK is a member of the Scientific Editorial Board of European Radiology Experimental (section editor: Cell/tissue, animal, digital models of human physiopathology) and, as such, did not participate in the selection or review processes for this article. The other authors have no conflicts of interest to declare.
